Smartleaf Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$131K Sell
1,173
-154
-12% -$21.5K ﹤0.01% 982
2025
Q4
$221K Buy
1,327
+175
+15% +$27.4K 0.01% 762
2025
Q3
$143K Buy
1,152
+39
+4% +$4.74K 0.01% 877
2025
Q2
$138K Sell
1,113
-93
-8% -$11.8K 0.01% 728
2025
Q1
$161K Buy
1,206
+149
+14% +$22.9K 0.02% 643
2024
Q4
$152K Buy
1,057
+499
+89% +$71.6K 0.02% 645
2024
Q3
$81.4K Buy
558
+495
+786% +$71K 0.01% 772
2024
Q2
$7.97K Buy
63
+45
+250% +$7.05K ﹤0.01% 1537
2024
Q1
$3.33K Buy
18
+17
+1,700% +$3.24K ﹤0.01% 1352
2023
Q4
$0 Buy
+1
New +$156 ﹤0.01% 1216

Other funds holding RGEN

Smartleaf Asset Management's RGEN Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Repligen (RGEN) stake by 12% in Q1 2026, selling an estimated $21.5K and leaving 1,173 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #982.

Smartleaf Asset Management first reported a position in RGEN in Q4 2023 and has held it in 10 quarters since. The position peaked at $221K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Smartleaf Asset Management held 1,173 shares of Repligen worth $131K as of Q1 2026.
  • Smartleaf Asset Management sold 154 Repligen shares in Q1 2026, an estimated $21.5K.
  • Repligen made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #982 holding.
  • Smartleaf Asset Management first reported a position in Repligen in Q4 2023 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Repligen position peaked at $221K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.